"Neuromuscular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Descriptor ID |
D009468
|
| MeSH Number(s) |
C10.668
|
| Concept/Terms |
Foley-Denny-Brown Syndrome- Foley-Denny-Brown Syndrome
- Foley Denny Brown Syndrome
- Syndrome, Foley-Denny-Brown
- Fasciculation-Cramp Syndrome, Benign
- Benign Fasciculation-Cramp Syndrome
- Benign Fasciculation-Cramp Syndromes
- Fasciculation Cramp Syndrome, Benign
- Fasciculation-Cramp Syndromes, Benign
- Cramp-Fasciculation Syndrome
- Cramp Fasciculation Syndrome
- Cramp-Fasciculation Syndromes
- Syndrome, Cramp-Fasciculation
- Syndromes, Cramp-Fasciculation
Oppenheim Disease- Oppenheim Disease
- Oppenheim's Disease
- Oppenheims Disease
- Amyotonia Congenita
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Diseases".
This graph shows the total number of publications written about "Neuromuscular Diseases" by people in this website by year, and whether "Neuromuscular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 1 | 6 |
| 2018 | 4 | 0 | 4 |
| 2019 | 3 | 1 | 4 |
| 2020 | 6 | 2 | 8 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Neuromuscular Diseases" by people in Profiles.
-
Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol. 2021 10 01; 34(5):669-674.
-
Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic. Toxins (Basel). 2021 08 22; 13(8).
-
Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy. Muscle Nerve. 2021 10; 64(4):474-482.
-
Impact of the COVID-19 pandemic on biopsychosocial health and quality of life among Danish children and adults with neuromuscular diseases (NMD)-Patient reported outcomes from a national survey. PLoS One. 2021; 16(6):e0253715.
-
How to manage with telemedicine people with neuromuscular diseases? Neurol Sci. 2021 Sep; 42(9):3553-3559.
-
Just Breathe: Tips and Highlights for Managing Pediatric Respiratory Distress and Failure. Emerg Med Clin North Am. 2021 Aug; 39(3):493-508.
-
[Neuromuscular complications of SARS-CoV-2 infection-Part 2: muscle disorders]. Nervenarzt. 2021 Jun; 92(6):548-555.
-
Pathophysiology and management of critical illness polyneuropathy and myopathy. J Appl Physiol (1985). 2021 05 01; 130(5):1479-1489.
-
Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med. 2021 03 10; 13(584).
-
COVID-19 as the trigger for respiratory failure in neuromuscular diseases. Arq Neuropsiquiatr. 2021 03; 79(3):264-265.